Contact Us

MEETING NEWS

ebm-papst A&NZ Achieves Complete Operational Carbon Neutrality in appropriate Scope 1,2 and 3 criterion in 2023

Jan 3, 2025

MELBOURNE,Australia,Dec. 25,2024-- Recently,ebm-papst Australia & New Zealand (A&NZ) announced the achievement of operational carbon neutrality for its Australian business operations,covering

Microtech Announces First Human Case of Implantable Microsensor for Heart Failure

Jan 3, 2025

TEL AVIV,Israel,Dec. 26,2024-- Microtech,a wholly owned subsidiary of Medinol Inc.,a leader in global MedTech research and development,announced that it has initiated human clinical trials of their m

IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved

Jan 3, 2025

SUZHOU,China,Dec. 26,2024-- Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033,a high-concentration subcutaneous co-formulation consi

Huawei Cloud Named a Challenger in Gartner® Magic Quadrant™ for Cloud DBMSs

Jan 3, 2025

SHENZHEN,China,Dec. 27,2024-- Huawei Cloud was named a Challenger in theMagic Quadrant for Cloud Database Management Systems,2024 report released recently by Gartner,a renowned international research

VISTA Eye Specialist Revolutionizes Dry Eye Treatment with Groundbreaking Research and Advanced Technology

Jan 3, 2025

PETALING JAYA,Malaysia,Dec. 27,2024-- VISTA Eye Specialist (VISTA),Malaysia\'s leading eye care provider,proudly announces a major milestone in the treatment of dry eye disease. A groundbreaking study

SM approaches 2025 with cautious optimism

Jan 3, 2025

PASAY CITY,Philippines,Dec. 27,2024-- TheSM Group is approaching the coming year with cautious optimism,encouraged by the continued growth of the Philippine economy.

1 ... 173 174 175 176 177 178 179 ... 381